KAINOS Laboratories (TSE:4556) Days Sales Outstanding : 114.96 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is KAINOS Laboratories Days Sales Outstanding?

KAINOS Laboratories's average Accounts Receivable for the three months ended in Dec. 2023 was 円1,640 Mil. KAINOS Laboratories's Revenue for the three months ended in Dec. 2023 was 円1,302 Mil. Hence, KAINOS Laboratories's Days Sales Outstanding for the three months ended in Dec. 2023 was 114.96.

The historical rank and industry rank for KAINOS Laboratories's Days Sales Outstanding or its related term are showing as below:

TSE:4556' s Days Sales Outstanding Range Over the Past 10 Years
Min: 68.67 Med: 74.39 Max: 111.21
Current: 111.21

During the past 13 years, KAINOS Laboratories's highest Days Sales Outstanding was 111.21. The lowest was 68.67. And the median was 74.39.

TSE:4556's Days Sales Outstanding is ranked worse than
83.04% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 64.065 vs TSE:4556: 111.21

KAINOS Laboratories's Days Sales Outstanding increased from Dec. 2022 (112.32) to Dec. 2023 (114.96).

KAINOS Laboratories Days Sales Outstanding Historical Data

The historical data trend for KAINOS Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KAINOS Laboratories Days Sales Outstanding Chart

KAINOS Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

74.94

72.00

87.80

100.41

101.70

KAINOS Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															112.32	112.97	106.00	105.33	114.96

Competitive Comparison of KAINOS Laboratories's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

KAINOS Laboratories's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where KAINOS Laboratories's Days Sales Outstanding falls into.

KAINOS Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

KAINOS Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (1332.568	+	1410.951)	/	2 )	/	4923.245	*	365
=	1371.7595					/	4923.245	*	365
=	101.70

KAINOS Laboratories's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1639.489	+	1641.477)	/	2 )	/	1302.195	*	365 / 4
=	1640.483					/	1302.195	*	365 / 4
=	114.96

KAINOS Laboratories (TSE:4556) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

KAINOS Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of KAINOS Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

KAINOS Laboratories (TSE:4556) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KAINOS Laboratories Inc (TSE:4556) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

38-18, Hongo 2-chome, Bunkyo-ku,, Tokyo, JPN

Website

http://www.kainos.co.jp

KAINOS Laboratories, Inc. is focused on development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sale and export/import of physicochemical measuring equipment for medical use.

KAINOS Laboratories (TSE:4556) Headlines

No Headlines